Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

Li, Jianjun; Lü, Zhiyong; Kou, Wen‐Rong; Chen, Zuo; Wu, Yangfeng; Yu, Xiaoming; Zhao, Yue

doi:10.3109/07853891003652534

Cited by 43 publications

(39 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…And until now, the efficacy of CM for treating hypertension is suggested by a large number of published case series and uncontrolled trials [26–30]. Six randomized controlled trials [31–36] reported significant reductions in BP relative to randomly assigned control groups treated for 4 to 12 weeks, whereas the other six trials [37–42] reported negative results of CM relative to control subjects. For seeking the best evidence of CM in making decisions for hypertensive patients, a number of clinical studies have been conducted in China to gain credibility with the researchers' unremitting efforts.…”

Section: Introductionmentioning

confidence: 99%

Evidence-Based Chinese Medicine for Hypertension

Wang

Xiong

2013

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Hypertension is an important worldwide public -health challenge with high mortality and disability. Due to the limitations and concerns with current available hypertension treatments, many hypertensive patients, especially in Asia, have turned to Chinese medicine (CM). Although hypertension is not a CM term, physicians who practice CM in China attempt to treat the disease using CM principles. A variety of approaches for treating hypertension have been taken in CM. For seeking the best evidence of CM in making decisions for hypertensive patients, a number of clinical studies have been conducted in China, which has paved the evidence-based way. After literature searching and analyzing, it appeared that CM was effective for hypertension in clinical use, such as Chinese herbal medicine, acupuncture, moxibustion, cupping, qigong, and Tai Chi. However, due to the poor quality of primary studies, clinical evidence is still weak. The potential benefits and safety of CM for hypertension still need to be confirmed in the future with well-designed RCTs of more persuasive primary endpoints and high-quality SRs. Evidence-based Chinese medicine for hypertension still has a long way to go.

show abstract

Section: Introductionmentioning

confidence: 99%

Evidence-Based Chinese Medicine for Hypertension

Wang

Xiong

2013

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

show abstract

“…[7][8] The real clinical benefits of statins are due to their LDL-C lowering effects and this benefit has been observed in clinical trials. Rosuvastatin has been approved for use at doses of 5 -40 mg to reduce LDL-C and improve HDL and other parameters in dyslipidemic patients.…”

Section: Discussionmentioning

confidence: 99%

A Comparative Evaluation of Efficacy and Safety of Daily Dosing Versus Alternate Day Dosing of Rosuvastatin for Dyslipidemic Patients

Malhotra

Aslam

Gupta

2013

IJMDS

View full text Add to dashboard Cite

show abstract

“…A clinical trial of secondary prevention intervention conducted in China (Fig. 1) on a population of 4780 patients with coronary heart disease, of which 1445 over the age of 65, with follow-up of 7 years, gave surprising results in terms of reducing the risk of lethal and non-lethal recurrent events, probably compromised by the lack of other active interventions on patients considered [6].…”

Section: Monacolinmentioning

confidence: 97%